How to diagnose a posterior wall myocardial infarction (MI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Posterior Wall Myocardial Infarction

Posterior wall MI should be diagnosed using posterior leads (V7-V9) at the fifth intercostal space, with ST elevation ≥0.05 mV (or ≥0.1 mV in men >40 years old) considered diagnostic. 1

Standard ECG Findings Suggestive of Posterior MI

  • ST depression in leads V1-V3, especially when terminal T waves are positive (ST elevation equivalent) 1
  • Horizontal ST depression with upright T waves in precordial leads 1
  • Absence of diagnostic ST elevation in standard 12-lead ECG despite ongoing ischemic symptoms 1

Posterior Lead Placement and Interpretation

  1. Lead placement:

    • V7: Left posterior axillary line at the fifth intercostal space
    • V8: Left mid-scapular line at the fifth intercostal space
    • V9: Left paraspinal border at the fifth intercostal space 1
  2. Diagnostic criteria:

    • ST elevation ≥0.05 mV in leads V7-V9 is diagnostic
    • Specificity increases with ST elevation ≥0.1 mV (recommended for men >40 years old) 1
    • Pathologic Q waves may appear in leads V7-V9 in 75% of patients with confirmed posterior MI 2

Clinical Importance

  • Posterior MI accounts for 15-21% of all acute MIs, often occurring with inferior or lateral wall involvement 1
  • Isolated posterior MI occurs in approximately 4% of all AMI patients 2
  • Left circumflex coronary artery is typically the culprit vessel (identified in 94% of catheterized patients) 2, 3
  • Patients with posterior MI have:
    • Higher peak creatine kinase levels (larger infarct area)
    • Lower left ventricular ejection fraction
    • Higher incidence of adverse clinical events (reinfarction, heart failure, death) 4

Diagnostic Algorithm

  1. Initial assessment:

    • If standard 12-lead ECG shows ST depression in V1-V3 with upright T waves in a patient with ischemic symptoms, suspect posterior MI 1
  2. Additional ECG leads:

    • Immediately obtain posterior leads (V7-V9) 1
    • Consider right-sided leads (V3R-V4R) if inferior MI is also suspected to identify right ventricular involvement 1
  3. Interpret findings:

    • ST elevation ≥0.05 mV in V7-V9 confirms posterior wall involvement 1
    • Use higher threshold (≥0.1 mV) for men >40 years old 1
  4. Additional diagnostic testing:

    • Obtain cardiac biomarkers (troponin) 5
    • Consider echocardiography to assess for posterior wall motion abnormalities (present in 97% of posterior MI cases) 2

Clinical Pitfalls to Avoid

  • Missing the diagnosis: Posterior MI is often overlooked because standard 12-lead ECG lacks direct visualization of the posterior wall 1, 2
  • Delayed treatment: Without posterior leads, these patients may be misclassified as having unstable angina or non-ST elevation MI, potentially delaying appropriate reperfusion therapy 3
  • Failing to recognize the significance: ST depression in V1-V3 may be misinterpreted as non-specific changes rather than reciprocal changes of posterior wall ST elevation 1
  • Underestimating severity: Posterior MI is associated with larger infarct size and worse outcomes compared to isolated inferior MI 4

Treatment Implications

  • Patients with confirmed posterior MI should receive the same reperfusion therapy as those with ST-elevation MI 1
  • Early identification is crucial for proper triage and treatment 2
  • Patency of the infarct-related artery in posterior MI results in improved left ventricular ejection fraction at discharge 4

By systematically evaluating patients with suspected posterior MI using posterior leads, clinicians can identify these often-missed infarctions and provide appropriate reperfusion therapy, potentially improving outcomes in this high-risk population.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.